AxoGen (AXGN) Tops Q4 EPS by 4c

AxoGen (NASDAQ: AXGN) reported Q4 EPS of $0.07, $0.04 better than the analyst estimate of $0.03. Revenue for the quarter came in at $49.4 million versus the consensus estimate of $47.58 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Ericsson (ERIC) Tops Q2 EPS by 3c
• Antero Midstream Partners LP (AM) PT Raised to $24 at Goldman Sachs into earnings
• Needham Comments on CONMED (CNMD) Amid Sale Rumors